The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Eli Lilly (LLY) has bought the pain therapy developer 4E Therapeutics, the Austin-based neuroscience company announced on Tuesday, marking the weight loss drugmaker’s latest acquisition. 4E is a ...

Plug Power has spent nearly three decades developing a vertically integrated, end-to-end hydrogen ecosystem. To achieve this, the company has diversified into a range of products and services, ...

Plug Power has been in business for more than 25 years, but it reported its first-ever gross profit for the fourth quarter of 2025 only in March 2026. Its first-quarter earnings report in May ...

Swedish biotech AlzeCure Pharma announced on Tuesday a collaboration and a licensing agreement with Eli Lilly (LLY) to develop an Alzheimer’s therapy as part of a deal that could potentially exceed ...

Eli Lilly and Company (NYSE:LLY) rose around 12% in May 2026, primarily driven by strong FQ1 2026 earnings beat and FDA approval for Foundayo and expansion of insurance coverage of obesity treatment.

Retatrutide's 19% weight loss data pushed LLY to a 52-week high, and four straight EPS beats make the $1,500 optimistic target achievable. AZN's elecoglipron delivered only 12% weight loss in Phase 3 ...

Looking ahead to 2030, our model projects LLY could trade at an average price of $1,621.02, with a potential range between $1,215.76 and $2,026.27. This represents a potential 33.5% return from ...

Shares of global pharmaceutical company Eli Lilly (NYSE:LLY) jumped 2.1% in the afternoon session after the company reported positive Phase 3 data for retatrutide, its next-generation triple-agonist ...

The investment seeks daily leveraged investment results of two times (200%) the daily percentage change in the share price of Eli Lilly and Company. The fund is an actively managed exchange traded ...